These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31581605)

  • 21. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
    Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
    Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.
    Cirla AM; Cirla PE; Parmiani S; Pecora S
    Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous flow cytometric detection of basophil activation marker CD63 and intracellular phosphorylated p38 mitogen-activated protein kinase in birch pollen allergy.
    Aerts NE; Dombrecht EJ; Bridts CH; Hagendorens MM; de Clerck LS; Stevens WJ; Ebo DG
    Cytometry B Clin Cytom; 2009 Jan; 76(1):8-17. PubMed ID: 18727065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis.
    Burastero SE; Mistrello G; Paolucci C; Breda D; Roncarolo D; Zanotta S; Falagiani P
    Int J Immunopathol Pharmacol; 2009; 22(2):343-52. PubMed ID: 19505388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis.
    Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J
    J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.
    Håkansson L; Heinrich C; Rak S; Venge P
    J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India.
    Chakraborty P; Roy I; Chatterjee S; Chanda S; Gupta-Bharracharya S
    J Investig Allergol Clin Immunol; 2006; 16(6):377-84. PubMed ID: 17153886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
    Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
    J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical benefit of component-resolved diagnosis in Japanese birch-allergic patients with a convincing history of apple or peach allergy.
    Shirasaki H; Yamamoto T; Abe S; Kanaizumi E; Kikuchi M; Himi T
    Auris Nasus Larynx; 2017 Aug; 44(4):442-446. PubMed ID: 27816237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects.
    Winther L; Malling HJ; Mosbech H
    Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptoms.
    Wilson D; Evans M; Guthrie N; Sharma P; Baisley J; Schonlau F; Burki C
    Phytother Res; 2010 Aug; 24(8):1115-9. PubMed ID: 20549654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
    Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
    Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
    Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Dau c 1 in three different patterns of carrot-induced asthma.
    Moreno-Ancillo A; Gil-Adrados AC; Cosmes PM; Domínguez-Noche C; Pineda F
    Allergol Immunopathol (Madr); 2006; 34(3):116-20. PubMed ID: 16750122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest).
    Pâris-Köhler A; Demoly P; Persi L; Lebel B; Bousquet J; Arnoux B
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):339-45. PubMed ID: 10669856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.
    Pfaar O; van Twuijver E; Boot JD; Opstelten DJ; Klimek L; van Ree R; Diamant Z; Kuna P; Panzner P
    Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy for birch pollen-allergic patients: recent advances.
    Moingeon P; Floch VB; Airouche S; Baron-Bodo V; Nony E; Mascarell L
    Immunotherapy; 2016 May; 8(5):555-67. PubMed ID: 27140409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis.
    Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L
    Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.